High Quality Lab Tests Solutions by Medcillary
Medcillary helps you maximize patient care with the most up to date testing available.
Medical Laboratory science provides clues that are key in the diagnosis and treatment of disease or injury, and laboratory professionals are the detectives of the health care world. They provide clues that are key in the diagnosis and treatment of disease or injury and assist in the maintenance of healthy lifestyles.
Medcillary has multiple lab partners for physicians looking to build best-in-class testing regimens specific to their practice.
Our Blood Allergy testing is on the forefront of the Allergy testing industry. Instead of having a vile of blood collected or the old needle method, our Blood Allergy testing is collected via a Finger Stick device, much like a diabetes test. There are a total of 68 different allergens offered (28 Food Allergy Tests, 40 Environmental Allergy Tests).
This test helps physicians understand a patient’s allergies. In addition, the result from our testing helps physicians create a plan for patients of what to avoid and/or a plan of how to live a life with their allergies.
Physicians and patients should expect results in 3-5 business days from when the samples are received at the lab.
Our Cancer Genomics testing uses Next-Generation Sequencing machines. The highest standard in the Genomics Industry. Cancer Genomics testing measures your risk level of what types of cancers your genetic makeup exposes you too. Over 37 Gene mutations are tested, which detect hereditary cancers, such as Breast, Ovarian, Prostate, Hematologic, etc. Physicians use this test to put together a long-term preventative plan due to your genetic mutation results. This will help reduce the patient's risk of being exposed to certain types of cancers the individual is at risk for. This is a minimally invasive test as it is collected via an oral swab collection device. Genomics testing is some of the most informative testing physicians and patients have access to in today's diagnostic market.
At DTR Labs, we offer a Cardiac Genetic test through our Comprehensive Cardiomyopathy Panel. Cardiomyopathy is a disease of the heart muscle that makes it harder for your heart to pump blood to the rest of your body. Cardiomyopathy can lead to heart failure.
This test examines genes associated with hereditary cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction cardiomyopathy, and hereditary arrhythmogenic right ventricular cardiomyopathy. Patients identified with a hereditary cardiomyopathy can benefit from increased surveillance and preventative steps to better manage their risks. Medical intervention can include lifestyle changes, medications, implantable devices, medical procedures, and surgery. Also, your patient’s family members can be tested to help define their risk. If a pathogenic variant is identified in your patient, close relatives (children, siblings, parents) could have as high as a 50% risk to also be at increased risk.
This test is a fit for patients who have a family history of heart attacks, heart disease, and cardiomyopathy. Patients who are experiencing symptoms such as, Episodes of chest pain, Dizziness, Fatigue, Palpitations, Heart Arrhythmia, Abnormal heart rate, Shortness of breath, Swelling of the extremities, Significant Weight gain, history of Heart Attack, and history of heart disease.
Cardiomyopathy is a genetic swab test with an expected turnaround time of approximately two to four weeks from the time the lab receives the sample.
We perform PCR testing for Covid-19. PCR is the most accurate form of testing in the industry. It is used to precisely analyze the genetic material of pathogens and gives accurate and fast results back to providers to help treat the patient.
Our turnaround is 12-24 hours once the samples is received at the lab. Results are available back to physicians via our cloud-based portal. We also can send results directly to the patient.
A person’s genetics are listed as one of the most common causes of Diabetes and Obesity. Obesity is a multifactorial disease resulting from the interaction between genetic factors and lifestyle. Identification of rare genetic variations with strong effects on obesity has been useful in diagnosing and designing personalized therapy for early-onset or syndromic obesity. However, common variants identified in recent genome-wide association studies have limited clinical value. Family and adoption studies suggest that an estimated 20%–80% of population variance in BMI is due to genetic effects (ie, heritability).
Like type 1 diabetes, type 2 diabetes is inherited. This means a group of genes that can lead to type 2 is passed down from mothers and fathers to their children. Not everyone who inherits the genes will develop it, but if you have the genes for type 2 diabetes, you've got a greater chance of developing it. Although there's no cure for type 2 diabetes, studies show it's possible for some people to reverse it. Through diet changes and weight loss, you may be able to reach and hold normal blood sugar levels without medication.
Diabetes/Obesity Genetic Testing is for patients with a personal and/or family history suggestive of monogenic diabetes and obesity related disorders.
Diabetes/Obesity Genetic Testing is a genetic swab test with an expected turnaround time for results of two to four weeks from the time the lab receives the sample.
Malignant Hyperthermia is a biochemical chain reaction response, “triggered” by commonly used general anesthetics and the paralyzing agent succinylcholine (a neuromuscular blocker), within the skeletal muscles of susceptible individuals. The general signs of Malignant Hyperthermia include increased heart rate, increased body metabolism, muscle rigidity and/or fever that may exceed 110 degrees F along with muscle breakdown, derangements of body chemicals and increased acid content in the blood. Severe complications include cardiac arrest, brain damage, internal bleeding, or failure of other body systems. Thus, death, primarily due to a secondary cardiovascular collapse, can result.
Malignant Hyperthermia is a dominate gene and is passed down from generation to generation. A patient containing Malignant Hyperthermia has over a 50% chance of passing to their children.
You can test for Malignant Hyperthermia via DTR Labs Malignant Hyperthermia Genetic Testing. Patients this test is a good fit for are patients with a family history of Malignant Hyperthermia and patients with a history of complications of anesthesia during or after surgery.
Prior to surgery, knowing if an individual has Malignant Hyperthermia can be lifesaving. The condition can be treated. Every anesthetic must be associated with a plan for treatment of unanticipated Malignant Hyperthermia.
Malignant Hyperthermia is a genetic swab test with an expected turnaround time of two to four weeks from the time the lab receives the sample.
Alzheimer’s Disease, Parkinson’s Disease, and Dementia are conditions that affect the brain and spinal cord. They can cause serious complications, such as difficulty moving or experiencing involuntary movements (i.e. tremors), memory loss, and disruption of mental abilities (solving problems, controlling emotions, or chewing and swallowing). Symptoms of these conditions typically begin after the age of 60. Research has shown that these diseases can sometimes be caused by abnormal changes in our genes, and these genetic changes can be inherited and passed down in families. Having a family history of Parkinson’s disease, Alzheimer’s disease, dementia, or a similar condition may increase your risk of having that condition. There is no cure for Alzheimer’s disease, Parkinson’s disease, or dementia; however, there are treatments available to provide temporary relief from symptoms.
Genetic testing can identify individuals at increased risk and assist in the planning and decision-making process for treatment, psychosocial counseling, and support programs for caregivers and patients.
Alzheimers/Dementia/Parkinsons genetic testing is for patients with a family history of Parkinsons disease, Alzheimers disease, and/or Dementia. This test is a great fit for patients who are experiencing personal symptoms of these diseases which include, but are not limited to, abnormal imaging of the brain, difficulty moving or controlling one’s movement, memory loss that interferes with daily life, changes in mood and personality, difficulty having a conversation or completing familiar tasks, and confusion with the time or place.
Alzheimers/Dementia/Parkinsons Genetic testing is a simple swab test with an expected turnaround time of approximately two to four weeks from the time the lab receives the sample.
Pharmacogenetic (PGx) testing allows clinicians to better understand how their patients will respond to certain medications. With PGx testing, it’s possible to tailor medication plans to a patient’s specific genetic makeup. This can lead to reduced medical costs for patients and providers, safer medication plans, and more efficient drug efficacy.
Pharmacogenomics (PGx) testing can reveal if a person is a fast, normal, or slow metabolizer. A person’s metabolism changes the way their body responds to medication, including:
Excessive amounts of the drug accumulate in the bloodstream, resulting in ADRs.
· Lack of Efficacy
The bloodstream cannot absorb enough of the drug to achieve a therapeutic effect.
Normal amounts of the drug enter the bloodstream, but even this is enough to trigger severe reactions in people with hypersensitivity to the medication.
BENEFITS OF PHARMACOGENETIC TESTING:
Identify which drug may be most effective before treatment starts - PGx testing can help clinicians choose the most effective drug for each patient, minimize the risk of adverse reactions, and reduce hospitalizations.
Reduce the risk of adverse events related to certain drugs - PGx testing can assess a patient’s risk for adverse drug reactions before they take the medication which can improve patient safety and minimize costs for healthcare facilities.
Adjust and optimize the dose of current medications - PGx testing can help clinicians predict the appropriate dose of medication for their patient. This allows them to create more personalized medication plans to maximize efficacy and reduce pharmacy costs.
Improved Patient Care - PGx test results become part of a patient’s medical record, allowing physicians to make more informed decisions when prescribing medications for future medical issues.
PGx testing is a genetic swab test with an expected turnaround time of two to four weeks.
Our Respiratory Pathogen Panel (RPP) testing quickly identifies pathogens and detects potential antibiotic resistance, so effective treatment can begin sooner. Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.
Accurate diagnosis within 24-48 hours with real-time PCR for pathogen identification and detection of antibiotic resistance
· RT - PCR, is the most accurate form of testing in the industry for Respiratory testing. It is used to precisely analyze the genetic material of pathogens and gives accurate and fast results back to providers to help treat the patient
· Rapid and accurate solution eliminates guesswork in diagnosing and treating upper respiratory infections.
· Provides a more definitive diagnosis than Point of Care antigen assays
· Helps improve clinical confidence and decrease patient risks
· Detects polymicrobial infections
· Unaffected by concurrent antibiotic use
· Identifies potential antibiotic resistance
· Aids in quick clinical decision-making
· Reduces false negative results
· Aids in antibiotic stewardship
· Reduces potential unnecessary drug exposure and adverse events
· More accurate than conventional culture
Respiratory Pathogen Panel testing is collected via a nasopharyngeal swab. Physicians and a patients can expect results within 24-48 hours from when the sample arrives at the lab.
We offer both Urine Toxicology and Oral Fluid Toxicology. We use LC/MS machines at our lab, giving our physicians accurate results with the highest standard of testing available in the industry. Our Toxicology testing helps physicians monitor medications being prescribed with both qualitative and quantitative results. We have added rule based logic and drug testing history to our results, making our results more organized and more efficient to read for physicians working with our lab. We have certified Toxicologists on staff that are available for any questions our physicians may have.
Why Use Toxicology?
· Making sure medications being prescribed are working
· Medication monitoring/management
· Preventing accidental overdose or addiction to controlled substances being prescribed
· See how much of the drug you are prescribing your patients are taking (quantitative results)
· Preventing harmful drug to drug interactions the patient may be taking
· Check for community abused drugs your patients may be taking in congruence with medications being prescribed
· Prevent drug diversion
Our Urinary Tract Infection testing uses Real-Time PCR. This is a more accurate test than previous methods in the industry. With PCR machines we can yield a faster result turnaround time for results so physicians can begin treating patients faster. With 26+ organisms that can be detected, this test will help physicians identify if you have a UTI. Older patients using controlled substances for a longer period are also at a higher risk than the average person. The result of this test helps physicians prescribe the correct medication for what UTI the patient is showing positive for.
Medcillary helps you maximize patient care with the most up to date testing available.